GB202213032D0 - Dosage regime - Google Patents
Dosage regimeInfo
- Publication number
- GB202213032D0 GB202213032D0 GBGB2213032.2A GB202213032A GB202213032D0 GB 202213032 D0 GB202213032 D0 GB 202213032D0 GB 202213032 A GB202213032 A GB 202213032A GB 202213032 D0 GB202213032 D0 GB 202213032D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- dosage regime
- regime
- dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2213032.2A GB202213032D0 (en) | 2022-09-07 | 2022-09-07 | Dosage regime |
PCT/GB2023/051565 WO2023242578A1 (en) | 2022-06-16 | 2023-06-15 | Dosage regimen for a combination therapy consisting oftcr-engineered t-cells in combination with a pd-1 axis binding antagonist |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2213032.2A GB202213032D0 (en) | 2022-09-07 | 2022-09-07 | Dosage regime |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202213032D0 true GB202213032D0 (en) | 2022-10-19 |
Family
ID=83933368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2213032.2A Ceased GB202213032D0 (en) | 2022-06-16 | 2022-09-07 | Dosage regime |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202213032D0 (en) |
-
2022
- 2022-09-07 GB GBGB2213032.2A patent/GB202213032D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2595776B (en) | Therapeutic solid dosage forms | |
IL291452A (en) | Dosage forms for tyk2 inhibitors | |
GB202020191D0 (en) | Pharmaceutical compounds | |
GB202010409D0 (en) | Pharmaceutical compounds | |
GB202213032D0 (en) | Dosage regime | |
GB202212323D0 (en) | Dosage regime | |
GB202208849D0 (en) | Dosage regime | |
GB202200753D0 (en) | Pharmaceutical compounds | |
GB202111193D0 (en) | Pharmaceutical compounds | |
GB202010408D0 (en) | Pharmaceutical compounds | |
GB202316063D0 (en) | Dosing regime | |
GB202304987D0 (en) | Combination pharmaceutical | |
GB202216306D0 (en) | Combination pharmaceutical | |
GB202203093D0 (en) | Medicament | |
IL308389A (en) | Dosage regimens for ecubectedin | |
IL289020A (en) | Antibacterial dosage regime using cannabinoids | |
GB201808507D0 (en) | Dosage Regime | |
GB201808473D0 (en) | Dosage regime | |
GB201808101D0 (en) | Dosage regime | |
GB202312534D0 (en) | Pharmaceutical compounds | |
GB202311227D0 (en) | Pharmaceutical compounds | |
GB202311018D0 (en) | Pharmaceutical compounds | |
GB201803298D0 (en) | Dosage regime | |
GB201802679D0 (en) | Dosage regime | |
EP4098594A4 (en) | Drug feeder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |